| 发明名称 |
TREATMENT OF CEREBRAL DISORDERS |
| 摘要 |
A method of treatment of schizophrenia or other chronic cerebral disorder in which cerebral atrophy is shown, is characterised in that one or more assimilable or pharmaceutically acceptable indium caesium or cerium compounds is associated with a pharmaceutically acceptable diluent or carrier. |
| 申请公布号 |
AU1875688(A) |
申请公布日期 |
1989.01.12 |
| 申请号 |
AU19880018756 |
申请日期 |
1988.07.06 |
| 申请人 |
EFAMOL HOLDINGS PLC |
发明人 |
DAVID FREDERICK HORROBIN;FRANK CORRIGAN |
| 分类号 |
A61K31/20;A61K31/202;A61K31/24;A61K31/28;A61K33/00;A61K33/24;A61P25/18;A61P25/28 |
主分类号 |
A61K31/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
